Abstract
The diagnosis and treatment of osteoporosis is still a relatively young science. Although Albright first described osteoporosis in 19471 it is only since the late 1980s and early 1990s that we have had the instruments available to us for the diagnosis and then treatment of this disease. Like any medical area in its infancy, we can therefore expect a significant number of changes in the coming years, as the understanding of bone physiology becomes more comprehensive and the genetic factors leading to increased risk factors become known.
Second to being right in this world is being totally wrong.
T.H. Huxley
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albright F. Annals of Internal Medicine Volume 27, 1947: Osteoporosis. Nutr Rev 1989; 47: 85–6.
Hollingworth W, Todd CJ, Parker MJ. The cost of treating hip fractures in the twenty-first century: short report. Osteoporos Int 1996; 6 (Suppl 2): 13–15.
Lindsay R, Cosman F, Lobo RA, Walsh BW, Harris ST, Reagan JE, Liss CL, Melton ME, Byrnes CA. Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial. J Clin Endocrinol Metab 1999; 84 (9): 3076–81.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag London
About this chapter
Cite this chapter
Miller, C.G. (2002). Future Therapies and Clinical Trials. In: Pearson, D., Miller, C.G. (eds) Clinical Trials in Osteoporosis. Springer, London. https://doi.org/10.1007/978-1-4471-3710-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3710-8_14
Publisher Name: Springer, London
Print ISBN: 978-1-85233-229-7
Online ISBN: 978-1-4471-3710-8
eBook Packages: Springer Book Archive